Press Releases

Get the latest on BIO's announcements, positions and views on everything from healthcare to biofuels. 

Featured Press Releases
BIO Statement on the USMCA Biotech Corn Dispute…
Today the dispute settlement panel formed under the United States-Mexico-Canada Agreement (USMCA) issued a final ruling related to Mexico's restrictions on the importation of genetically modified (GM) corn. In response, John Crowley, President…
BIO Applauds the Inclusion of Important Health…
John F. Crowley, President and CEO of the Biotechnology Innovation Organization (BIO), today released the following statement ahead of an expected vote in the U.S. House of Representatives on a year-end government funding bill that includes many…
BIO Appoints Veteran Communications Leader Sarah…
Today, the Biotechnology Innovation Organization (BIO) named Sarah Alspach as its new executive vice president and chief communications officer. Alspach, a communications veteran, will join BIO’s senior leadership team. Her first day will be…
All Press Releases
  • Show All
Search
Results
Event Tags
May 31, 2019
Washington, D.C. (May 31, 2019) – Today, the Biotechnology Innovation Organization (BIO) released the 2019 Emerging Therapeutic Company Trend Report, highlighting ten years (2009-2018) of biotechnology funding and deal making across five areas:…
May 29, 2019
BIO announces the winner of this year’s Henri A. Termeer Biotechnology Visionary Award: Emil D. Kakkis, MD, PhD, President and Chief Executive Officer, Ultragenyx (NASDAQ: RARE) and Founder, EveryLife Foundation for Rare Diseases. The award,…
May 20, 2019
The Biotechnology Innovation Organization (BIO) today announced that former U.S. Department of Agriculture (USDA) Secretary and former two-term Governor of Iowa Tom Vilsack will receive the 12th annual George Washington Carver Award for Innovation…
May 17, 2019
Washington, DC (May 17, 2019) – The Biotechnology Innovation Organization (BIO) today applauds the Senate passage of the Pandemic and All-Hazards Preparedness and Advancing Innovation (PAHPAI) Act (S. 1379). The legislation would re-authorize…
May 14, 2019
Today, the Biotechnology Innovation Organization (BIO) released a new report, The State of Innovation in Highly Prevalent Chronic Diseases Volume IV: Alzheimer’s Disease Therapeutics, the fourth in a series on the innovation landscape of highly…
May 8, 2019
Washington, D.C. (May 8, 2019) – The Biotechnology Innovation Organization (BIO) and the National Institutes of Health (NIH) today announced an agreement to feature Small Business Innovation Research (SBIR)-funded early-stage biomedical companies in…
May 7, 2019
Biotechnology Innovation Organization (BIO) President and CEO Jim Greenwood today expressed support for a U.S. House of Representatives letter, authored by Representatives Cindy Axne (D-Iowa) and Adrian Smith (R-Neb.), requesting U.S. Environmental…
April 29, 2019
The Biotechnology Innovation Organization (BIO) today announced that Chairman and CEO of JPMorgan Chase & Co., Jamie Dimon – a leader in the banking industry and catalyst for innovation across American business, including the healthcare industry…
April 29, 2019
The Biotechnology Innovation Organization (BIO) today submitted comments supportive of the U.S. Environmental Protection Agency’s (EPA) “Proposed Rulemaking for Modifications to Fuel Regulations to Provide Flexibility for E15 and to…
April 16, 2019
Washington, D.C. (April 16, 2019) – The Biotechnology Innovation Organization (BIO) announced today the “Right Mix Matters” campaign to increase diversity and inclusion in the biotech industry. Following on its previously announced goals to increase…
gooddaybio-cover-final
Daily News You Can’t Afford to Miss

Read it in under 3 minutes!

The Good Day BIO newsletter is the only daily newsletter at the intersection of biotech, politics, and policy.